EX-99.1 13 dex991.htm FIVE-YEAR SUMMARY FIVE-YEAR SUMMARY

Albemarle Corporation and Subsidiaries

 

FIVE-YEAR SUMMARY   Exhibit 99.1

 

(In Thousands, Except for Per-Share Amounts and Footnote Share Data)

 

Years Ended December 31


   2004

    2003

    2002

    2001

    2000

 

Results of Operations

                                        

Net sales

   $ 1,513,737     $ 1,110,237     $ 1,007,918     $ 942,752     $ 941,449  

Costs and expenses

     1,411,656       1,017,413       905,099       844,302       791,287  
    


 


 


 


 


Operating profit

     102,081       92,824       102,819       98,450       150,162  

Interest and financing expenses

     (17,350 )     (5,376 )     (5,070 )     (5,536 )     (5,998 )

Other (expense) income, net(a)

     (12,887 )     607       3,358       4,282       3,337  
    


 


 


 


 


Income before income taxes

     71,844       88,055       101,107       97,196       147,501  

Income taxes

     17,005       13,890       28,086       29,029       45,725  
    


 


 


 


 


Income before cumulative effect of a change in accounting principle

     54,839       74,165       73,021       68,167       101,776  

Cumulative effect of a change in accounting principle, net(b)

     —         (2,220 )     —         —         —    
    


 


 


 


 


Net income

   $ 54,839     $ 71,945     $ 73,021     $ 68,167     $ 101,776  
    


 


 


 


 


Financial Position and Other Data

                                        

Total assets

   $ 2,442,745     $ 1,387,291     $ 1,200,398     $ 1,138,272     $ 981,803  

Operations:

                                        

Working capital

   $ 373,664     $ 271,298     $ 256,481     $ 79,824     $ 173,038  

Current ratio

     2.00 to 1       2.29 to 1       2.56 to 1       1.26 to 1       2.22 to 1  

Depreciation and amortization

   $ 97,268     $ 84,014     $ 80,603     $ 77,610     $ 73,750  

Capital expenditures

   $ 57,652     $ 41,058     $ 38,382     $ 49,903     $ 52,248  

Investments in joint ventures

   $ 9,913     $ 11,102     $ 2,714     $ 11,166     $ 6,890  

Acquisitions, net of cash acquired

   $ 785,247     $ 117,767     $ —       $ 113,245     $ 35,006  

Research and development expenses

   $ 31,273     $ 18,411     $ 16,485     $ 21,919     $ 26,201  

Gross margin as a % of net sales

     19.7       21.5       23.1       23.5       28.8  

Total long-term debt

   $ 944,631     $ 228,579     $ 190,628     $ 170,215     $ 97,980  

Equity(b)

   $ 711,375     $ 636,221     $ 574,337     $ 599,623     $ 565,228  

Total long-term debt as a % of total capitalization

     57.0       26.4       24.9       22.1       14.8  

Common Stock

                                        

Basic earnings per share(b)

   $ 1.32     $ 1.74     $ 1.73     $ 1.49     $ 2.22  

Shares used to compute basic earnings per share(c)

     41,567       41,255       42,104       45,766       45,882  

Diluted earnings per share(b)

   $ 1.29     $ 1.71     $ 1.69     $ 1.47     $ 2.18  

Shares used to compute diluted earnings per share(c)

     42,527       42,146       43,137       46,524       46,606  

Cash dividends declared per share

   $ .585     $ .565     $ .54     $ .52     $ .46  

Shareholders’ equity per share(c)

   $ 16.98     $ 15.46     $ 13.78     $ 13.18     $ 12.33  

Return on average shareholders’ equity

     8.1 %     11.9 %     12.4 %     11.7 %     19.2 %
    


 


 


 


 


 

Footnotes:

 

(a) Other (expense) income, net for 2004 includes foreign exchange hedging charges totaling $12,848 ($8,184 after income taxes) associated with contracts entered into by the Company to hedge the euro-denominated purchase price for the July 31, 2004 acquisition of the refinery catalysts business from Akzo Nobel N.V.

 

(b) On January 1, 2003, the Company implemented SFAS No. 143, “Accounting for Asset Retirement Obligations,” which addresses financial accounting and reporting for obligations associated with the retirement of tangible long-lived assets and the associated asset retirement costs.

 

(c) Shareholders’ equity includes the purchase of common shares amounting to: 2004—27,569; 2003—693,794; 2002—4,015,578; 2001—417,505 and 2000—574,091

 

97